Insight

Transfer pricing considerations resulting from COVID-19

Emerging issues that should be proactively considered

Burcin Nee

Burcin Nee

Principal, Economic & Valuation Services, KPMG US

+1 415-963-7073

Prita Subramanian

Prita Subramanian

Principal, Economic & Valuation Services, KPMG US

+1 617-988-1260

Mark Martin

Mark Martin

Principal, Washington National Tax, KPMG US

+1 713-319-3976

The unexpected outbreak of COVID-19 has significantly affected the global marketplace. As a result, transfer pricing issues are emerging that should be proactively considered.

Some common transfer pricing issues companies are addressing during this period of disruption are:

  • Financial transactions
  • Intercompany contracts
  • Managing disruption
  • Intangibles
  • Remote work
  • Operational transfer pricing
  • Tariffs
  • Dispute resolution and APAs

KPMG LLP's transfer pricing professionals (who are members of our Economic & Valuation Services practice) can help your company deal with transfer pricing challenges. We are supported by global transfer pricing professionals from KPMG International member firms around the world, helping us look beyond borders and understand the nuances of different national regulations.

Transfer pricing considerations resulting from COVID-19
June 8, 2020 | Download pdf to read more about the transfer issues companies are addressing in today's environment


 

Webcasts

More insights

Transfer Pricing Substance in Flux - DEMPE, BEPS 2.0, and Covid-19 (July 31, 2020)

Read more


Addressing Liquidity Issues during Covid-19 Using Intercompany Pricing Tools (July 20, 2020)

Read more


Transfer Pricing Adjustments to the COVID-19 Economic Downturn (July 6, 2020)

Read more


COVID-19 Disruption: International Tax and Transfer Pricing Issues (June 29, 2020)

Read more


COVID-19's Impact on Transfer Pricing in the Life Sciences Industry (June 29, 2020)

Read more


Revisiting Transfer Prices and Intercompany Contracts in Light of COVID-19 (June 22, 2020)

Read more


Transfer Pricing Considerations Resulting from COVID-19 (June 8, 2020)

Read more


COVID-19 and Transfer Pricing Policy: A Lookback Analysis Of Routine Returns (June 8, 2002)

Read more


Advance Pricing Agreements and COVID-19 (May 25, 2020)

Read more


Transfer Pricing and Potential Custom Tariff Opportunities in COVID-19 Environment (May 18, 2020)

Read more


Covid-19 Disruption in Life Sciences Industry—Tax, Trade, Value Chain Considerations (May 11, 2020)

Read more


Intangible Property Transfer Pricing in an Economic Downturn (May 11, 2020)

Read more


Transfer Pricing Implications for Intercompany Loans (COVID-19) (May 4, 2020)

Read more


COVID-19 Transfer Pricing Strategies for Private Equity Portfolio Companies (April 20, 2020)

Read more


Transfer Pricing Implications of COVID-19: Revisiting Pricing, Contracts, and APAs (April 15, 2020)

Read more


COVID-19 Puts Limited Risk Structure at Risk (March 26, 2020)

Read more